跳至主要内容
临床试验/ISRCTN17573492
ISRCTN17573492已完成未知

A double-blind randomised placebo-controlled feasibility study to assess the impact of octreotide infusion during liver transplantation on post-operative renal failure.

niversity College London0 个研究点目标入组 30 人开始时间: 2021年10月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged =18 years
  • 2. Undergoing primary liver transplantation of a whole or partial liver graft from a cardiac or brain dead donor
  • 3. Provision of written informed consent

排除标准

  • 1. Previous solid organ transplant
  • 2. Acute liver failure
  • 3. Fulminant hepatic failure
  • 4. Patients receiving a living donor liver graft
  • 5. Patients currently admitted to ICU prior to transplantation
  • 6. Requirement of haemodialysis or Continuous Veno-Venous Hemofiltration (CVVHF) pre-operatively
  • 7. Known allergy or adverse reaction to octreotide
  • 8. Pre-operative decision to use intra-operative CVVHF
  • 9. A positive pregnancy test

研究者

发起方
niversity College London

相似试验